These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29803939)

  • 41. Diverse cell signaling events modulated by perlecan.
    Whitelock JM; Melrose J; Iozzo RV
    Biochemistry; 2008 Oct; 47(43):11174-83. PubMed ID: 18826258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heparan sulfate fine structure and specificity of proteoglycan functions.
    Nakato H; Kimata K
    Biochim Biophys Acta; 2002 Dec; 1573(3):312-8. PubMed ID: 12417413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-glucose-induced structural changes in the heparan sulfate proteoglycan, perlecan, of cultured human aortic endothelial cells.
    Vogl-Willis CA; Edwards IJ
    Biochim Biophys Acta; 2004 Apr; 1672(1):36-45. PubMed ID: 15056491
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heparan sulfate proteoglycans and triglyceride-rich lipoprotein metabolism.
    Bishop JR; Stanford KI; Esko JD
    Curr Opin Lipidol; 2008 Jun; 19(3):307-13. PubMed ID: 18460924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mesenchymal stem cells, neural lineage potential, heparan sulfate proteoglycans and the matrix.
    Okolicsanyi RK; Griffiths LR; Haupt LM
    Dev Biol; 2014 Apr; 388(1):1-10. PubMed ID: 24509075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Augmented synthesis and differential localization of heparan sulfate proteoglycans in Duchenne muscular dystrophy.
    Alvarez K; Fadic R; Brandan E
    J Cell Biochem; 2002; 85(4):703-13. PubMed ID: 11968010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane.
    Tamura M; Natori K; Kobayashi M; Miyamura T; Takeda N
    J Virol; 2004 Apr; 78(8):3817-26. PubMed ID: 15047797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Agrin: an extracellular matrix heparan sulfate proteoglycan involved in cell interactions and synaptogenesis.
    Cole GJ; Halfter W
    Perspect Dev Neurobiol; 1996; 3(4):359-71. PubMed ID: 9117266
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heparan sulfate proteoglycans fine-tune macrophage inflammation via IFN-β.
    Gordts PL; Esko JD
    Cytokine; 2015 Mar; 72(1):118-9. PubMed ID: 25573804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombin reduces large heparan sulfate proteoglycan molecules in cultured vascular endothelial cell layers through inhibition of core protein synthesis.
    Fujii N; Kaji T; Akai T; Koizumi F
    Thromb Res; 1997 Nov; 88(3):299-307. PubMed ID: 9526950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteoglycans in liver cancer.
    Baghy K; Tátrai P; Regős E; Kovalszky I
    World J Gastroenterol; 2016 Jan; 22(1):379-93. PubMed ID: 26755884
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glomerular proteoglycans in diabetes. Partial structural characterization and metabolism of de novo synthesized heparan-35SO4 and dermatan-35SO4 proteoglycans in streptozocin-induced diabetic rats.
    Klein DJ; Brown DM; Oegema TR
    Diabetes; 1986 Oct; 35(10):1130-42. PubMed ID: 2944782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide.
    Buée L; Ding W; Anderson JP; Narindrasorasak S; Kisilevsky R; Boyle NJ; Robakis NK; Delacourte A; Greenberg B; Fillit HM
    Brain Res; 1993 Nov; 627(2):199-204. PubMed ID: 8298962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glycosaminoglycans, hyperglycemia, and disease.
    Hiebert LM; Han J; Mandal AK
    Antioxid Redox Signal; 2014 Sep; 21(7):1032-43. PubMed ID: 24224492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
    Schneider JG; Zhu Y; Coleman T; Semenkovich CF
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2699-706. PubMed ID: 17951320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and characterization of ligands for L-selectin in the kidney. III. Characterization of L-selectin reactive heparan sulfate proteoglycans.
    Watanabe N; Kawashima H; Li YF; Miyasaka M
    J Biochem; 1999 Apr; 125(4):826-31. PubMed ID: 10101298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer's disease.
    Shimizu H; Ghazizadeh M; Sato S; Oguro T; Kawanami O
    J Clin Neurosci; 2009 Feb; 16(2):277-82. PubMed ID: 19091577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of heparan sulfate in immune system-blood vessel interactions.
    Ihrcke NS; Wrenshall LE; Lindman BJ; Platt JL
    Immunol Today; 1993 Oct; 14(10):500-5. PubMed ID: 8274190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis.
    Kunjathoor VV; Chiu DS; O'Brien KD; LeBoeuf RC
    Arterioscler Thromb Vasc Biol; 2002 Mar; 22(3):462-8. PubMed ID: 11884291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional binding of secreted molecules to heparan sulfate proteoglycans in Drosophila.
    Baeg GH; Perrimon N
    Curr Opin Cell Biol; 2000 Oct; 12(5):575-80. PubMed ID: 10978892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.